Novo Nordisk Announces Extraordinary General Meeting for Board Election

Novo Nordisk A/S has announced the convening of an Extraordinary General Meeting (EGM) to elect new members to its Board of Directors. The decision follows a disagreement between the Novo Nordisk Board and the Novo Nordisk Foundation regarding the future composition of the Board. The Board proposed a renewal focusing on adding new competencies while maintaining continuity, whereas the Foundation sought a more extensive reconfiguration. As a result, Chair Helge Lund, Vice Chair Henrik Poulsen, and several independent board members will not stand for re-election. The EGM is scheduled for November 14, 2025, and the notice will be issued separately. The company will also host a conference call for investors on October 21, 2025.